Citicoline (CDP-Choline)
CDP-choline · Cytidine 5′-diphosphocholine · Cognizin · Somazina · Ceraxon
Last updated
At a glance
Overview
Why CDP-Choline Earned Its Spot in the Nootropic Stack#
Citicoline has become the default choline source for anyone serious about cognition — not because it's flashy, but because it does exactly what it claims with a safety profile that's been stress-tested in thousands of stroke patients at doses up to 2 g/day. It's the rate-limiting intermediate in phosphatidylcholine synthesis, which means it feeds two pathways at once: acetylcholine production (the attention and memory side) and neuronal membrane repair (the long-game neuroprotection side). Unlike Alpha-GPC, it also nudges dopamine and norepinephrine upward, which is why users consistently describe the feel as "focus with drive" rather than the flat cholinergic load some get from GPC.
Physique-focused users pick it up for four reasons: as a daily focus tool stacked with caffeine and L-theanine, as a mandatory cofactor with racetams (piracetam without a choline source reliably produces headaches), as a mood and cognition buffer on harsh oral cycles where superdrol or anadrol flatten affect, and as a long-term membrane-maintenance play in longevity stacks. Oral bioavailability sits above 90%, it crosses the BBB cleanly, and there's no tolerance, no withdrawal, and no hormonal axis involvement — it's an endogenous substrate you're topping up.
"Citicoline is well absorbed with oral bioavailability over 90% and has been demonstrated to have a very favorable safety profile in large, controlled populations." — Secades et al., Journal of Stroke and Cerebrovascular Diseases (2016)
The rest of this page covers where the effective dose actually plateaus (spoiler: most users overshoot), how to run it with racetams without getting headaches, the caffeine/theanine and on-cycle stacks that get the most mileage out of it, and the handful of side effects — GI upset, late-day insomnia, the TMAO question — worth knowing before you scale past 1 g/day.
How Citicoline (CDP-Choline) works
The Kennedy Pathway and Membrane Phospholipid Synthesis#
Citicoline is the endogenous rate-limiting intermediate in the Kennedy pathway — the biochemical assembly line that builds phosphatidylcholine (PC), the dominant phospholipid in neuronal membranes. Orally ingested CDP-choline is hydrolyzed in the gut and liver to cytidine and choline, both of which independently cross the blood-brain barrier and are re-synthesized back into CDP-choline inside neurons. From there it's incorporated directly into membrane PC, sphingomyelin, and cardiolipin pools.
Practically: you're feeding the raw substrate for neuronal membrane repair and mitochondrial membrane integrity. This is the mechanism that underlies citicoline's unusually long use-windows (12+ months in clinical trials) — you're not agonizing a receptor, you're topping up a structural pool.
"Citicoline is well absorbed with oral bioavailability over 90% and has been demonstrated to have a very favorable safety profile in large, controlled populations." — Secades JJ et al., Journal of Stroke and Cerebrovascular Diseases, 2016
Acetylcholine Precursor Loading#
The choline fraction feeds directly into acetylcholine (ACh) synthesis via choline acetyltransferase, raising cortical and striatal ACh output. This is the mechanistic basis for the subjective attention and working-memory lift users feel within the first week, and it's why citicoline is the standard cofactor for racetam stacks — piracetam, aniracetam, and oxiracetam all accelerate ACh turnover, and without an exogenous choline source you end up with depleted pools, brain fog, and the classic "racetam headache."
"Both doses of citicoline (250 mg and 500 mg) were associated with significantly improved attention and psychomotor speed compared to placebo after 28 days." — McGlade E et al., Journal of Attention Disorders, 2019
Dopaminergic and Monoaminergic Modulation#
This is what separates citicoline from Alpha-GPC subjectively. Animal and human data show citicoline increases striatal dopamine via enhanced tyrosine hydroxylase activity and reduced dopamine reuptake, plus modest elevations in cortical norepinephrine and serotonin. The result is a cleaner "focus + drive" profile rather than the occasional flat affect some users report on Alpha-GPC.
For physique-focused users, the practical payoff is mood and motivation support during harsh oral AAS cycles (superdrol, anadrol, M1T) where on-cycle anhedonia and irritability are common. Pairs well with tyrosine in the morning.
Neuroprotection and Membrane Stabilization#
Under metabolic or ischemic stress, neuronal membranes leak free fatty acids via phospholipase A2 activation, triggering apoptotic cascades. Citicoline inhibits PLA2, reduces free fatty acid release, upregulates Sirtuin-1, and preserves cardiolipin — which keeps mitochondrial function intact when neurons are under load.
"Citicoline was associated with a significantly lower proportion of patients showing cognitive decline and improved attention/executive function over 12 months. The treatment was well tolerated." — Alvarez-Sabín J et al., Cerebrovascular Diseases, 2013
This is the mechanism that makes citicoline useful in post-concussion protocols for combat- and contact-sport athletes, and why the longevity-stack crowd runs 500 mg indefinitely alongside creatine and omega-3s: you're maintaining membrane PC as endogenous synthesis declines with age.
Pharmacokinetic Behaviour#
Citicoline's kinetics are worth understanding because they drive dosing logic. Oral bioavailability is ~90–95% — essentially equivalent to IV, because the molecule is hydrolyzed pre-absorption and reconstituted intracellularly anyway. Plasma choline peaks at ~1 hour, with a second peak around 24 hours after hepatic redistribution. Terminal half-lives are long: ~56 hours for the choline fraction, ~71 hours for cytidine.
The long half-life is why twice-daily dosing (AM + early afternoon) works well and why late-day dosing disrupts sleep — you're layering cholinergic and dopaminergic tone on top of residual drug from the previous day. Food effect is minimal, so timing can be anchored to whenever you want the cognitive lift.
Protocol
| Level | Dose | Frequency | Notes |
|---|---|---|---|
| Low | 250–500 mg | Twice daily | Documented entry-level range |
| Mid | 500–1000 mg | Twice daily | Most commonly studied range |
| High | 1000–2000 mg | Twice daily | Dose AM and early afternoon. Avoid late-day dosing — overstimulation can disrupt sleep. Food effect is minimal. |
Cycle length & outcomes
Documented cycle
4–52 weeks
Plateau after
12 wks
Cycle Notes#
Citicoline isn't a "cycle" compound in the traditional sense — it's an endogenous substrate in the Kennedy pathway, not an exogenous hormone or receptor agonist that desensitizes with chronic exposure. No loading phase, no taper, no PCT, no tolerance curve. You can run it continuously for a year (the Álvarez-Sabín 2013 post-stroke cohort did exactly that with no safety signal) or pulse it for specific cognitive demands.
That said, there's still a goal-based structure worth following:
| Goal | Cycle Length | Daily Dose |
|---|---|---|
| Daily focus stack (caffeine + theanine) | Continuous | 250–500 mg AM |
| Racetam cofactor (piracetam, aniracetam, oxiracetam) | Matches racetam cycle | 500 mg BID |
| On-cycle mood/cognition buffer (harsh orals — superdrol, anadrol, M1T) | Duration of AAS cycle | 500 mg AM |
| Post-concussion / TBI recovery | 8–12 weeks | 1,000–2,000 mg split BID |
| Post-stroke / vascular cognitive impairment | 6–12 months | 1,000 mg split BID |
| Age-related cognitive maintenance (longevity) | Continuous | 500 mg AM |
Onset Timing#
Acute effects (focus, mild drive, headache-prevention when stacked with racetams) are felt within 45–90 minutes of the first dose — this tracks the ~1 h Tmax on the choline fraction. You don't need to "build up" a response.
Chronic effects (attention, psychomotor speed, executive function) show up in the controlled data around the 28-day mark:
"Both doses of citicoline (250 mg and 500 mg) were associated with significantly improved attention and psychomotor speed compared to placebo after 28 days." — McGlade et al., J Atten Disord (2019)
For post-stroke cognitive endpoints, the meaningful separation from placebo appeared at 6–12 months:
"Citicoline was associated with a significantly lower proportion of patients showing cognitive decline and improved attention/executive function over 12 months. The treatment was well tolerated." — Álvarez-Sabín et al., Cerebrovasc Dis (2013)
Translation for the nootropic user: you'll feel something on day one, but the real cognitive payoff compounds over weeks of consistent dosing.
Loading, Tapering, and Breaks#
- Loading: Not required. Plasma and CNS choline/cytidine pools equilibrate within the first few doses.
- Tapering: Not required. No rebound, no withdrawal, no HPA axis or hormonal involvement. You can stop cold.
- Breaks: Optional. Some users cycle 8 weeks on / 2 weeks off to reset subjective response, but there's no pharmacological basis for it — the most robust long-term dataset (12 months continuous, 1,000 mg/day) showed sustained benefit without tolerance.
Dose Ceiling and Dose-Response#
This is a plateau compound, not a linear one. The Clark 1997 dose-response in acute stroke found 500 mg outperformed both 1,000 mg and 2,000 mg on functional outcome:
"The best outcomes were seen in the 500 mg group, in which favorable outcome was achieved in 25% of patients... Citicoline was safe and well tolerated at all doses." — Clark et al., Neurology (1997)
For healthy nootropic users, this matters: 500 mg/day is the practical sweet spot. Scaling to 1–2 g adds cost and GI side effects without proportional cognitive return unless you're treating actual neurological injury.
Timing Within the Day#
Dose AM and early afternoon (before 2 PM for the second dose). The dopaminergic and cholinergic lift is mild but real, and late-day dosing is the single most common reason users report "citicoline gave me insomnia." It didn't — bad timing did.
Bloodwork#
None required. This is a supplement with a decade-plus safety record across stroke populations:
"Citicoline is well absorbed with oral bioavailability over 90% and has been demonstrated to have a very favorable safety profile in large, controlled populations." — Secades et al., J Stroke Cerebrovasc Dis (2016)
If you're running 1,000+ mg/day long-term, a standard CMP every 6–12 months is reasonable housekeeping — but there is no hepatotoxicity or lipid signal in the trial data to chase.
Practical Bottom Line#
Pick a dose (start at 250–500 mg AM), dose it consistently, don't dose it late, and keep it running as long as the goal is active. It stacks cleanly with essentially everything — caffeine, theanine, racetams, tyrosine, creatine, omega-3, AAS cycles, peptide protocols — and has no meaningful interactions to manage. Set it and forget it.
Risks & mistakes
Common (most users)#
- Mild GI upset (nausea, loose stools, abdominal discomfort) — almost always shows up at ≥1,000 mg/day. Split the dose BID, take with food, or drop to 500 mg/day.
- Headache — usually signals excess cholinergic load rather than deficit. Counterintuitive for people stacking it against racetam headaches, but if citicoline itself is the trigger, pull back to 250 mg.
- Insomnia or overstimulation — entirely a timing problem. Dose AM and no later than early afternoon. The dopaminergic lift plus cytidine's ~71 h half-life means late dosing stacks over days.
- Mild jitteriness when combined with caffeine — drop caffeine before dropping citicoline; adding 200 mg L-theanine usually fixes it.
Uncommon (dose-dependent or individual)#
- Transient hypotension or tachycardia — rare, mostly at 2 g/day. Not clinically meaningful in healthy users but noticeable if you're already on tadalafil or other vasodilators.
- Flat or blunted affect — some users get this at higher doses (more common with Alpha-GPC, but possible here). Reduce dose or switch choline source.
- Appetite suppression — minor, via the dopaminergic arm. Usually welcome on a cut, unhelpful on a bulk.
- Mild LFT elevations at chronic multi-gram dosing — no strong hepatotoxicity signal in the literature, but if you're running 1,500–2,000 mg/day for months alongside orals, include ALT/AST in your standard cycle panel.
"Citicoline is well absorbed with oral bioavailability over 90% and has been demonstrated to have a very favorable safety profile in large, controlled populations." — Secades et al., J Stroke Cerebrovasc Dis (2016)
Rare but serious#
- Mania or hypomania destabilization in users with a bipolar spectrum history — the dopamine/norepinephrine lift can tip a susceptible user. Warning signs: pressured speech, decreased sleep need, racing thoughts. Stop immediately.
- Severe or persistent headache that doesn't resolve on dose reduction — stop and reassess; this is not a compound worth pushing through symptoms for.
- Allergic/hypersensitivity reactions — extremely rare, standard presentation (rash, swelling). Discontinue.
"Citicoline was associated with a significantly lower proportion of patients showing cognitive decline and improved attention/executive function over 12 months. The treatment was well tolerated." — Alvarez-Sabín et al., Cerebrovasc Dis (2013)
Hard contraindications#
- Pregnancy and lactation — human data are insufficient. Default to avoiding.
- Active bipolar mania or untreated bipolar disorder — do not add a dopaminergic agent to an unstable mood picture.
- Late-day dosing — not a medical contraindication, but a protocol one. The biphasic kinetics (choline ~56 h, cytidine ~71 h) mean evening doses sabotage sleep for multiple days.
Gender, PCT, and cycle considerations#
No sex-specific dosing. Citicoline does not touch the HPTA, does not aromatize, does not affect SHBG, and has no PCT implications — it can be run straight through cycle, bridge, PCT, and off-cycle without interruption. Women tolerate it identically to men at the same absolute doses. Pregnancy data are limited, so pause it if trying to conceive or pregnant. For users running harsh orals (superdrol, anadrol, M1T) or high-dose trenbolone where cognitive fog and mood flattening are common, 500 mg/day is one of the few genuinely low-risk additions to the support stack.
Stack & combine
Multipliers applied when these compounds run together. Values > 1 indicate a bonus on that axis. Tap a partner to expand the mechanism.
| Partner | Type | Lean | Fat loss | Recovery |
|---|---|---|---|---|
| synergistic | ×1.02 | ×1.00 | ×1.12 |
Featured in stacks1 curated protocol include Citicoline (CDP-Choline)
FAQ — Citicoline (CDP-Choline)
Research & citations
5 studies cited on this page.
Conclusion
CDP-choline (citicoline) is one of the most reliable nootropic cofactors for attention, memory, and racetam synergy — high oral bioavailability, no hormonal impact, and easy to tailor to your use-case.
Key takeaways:
- Standard dose: 250–500 mg once or twice daily for most cognition-focused users
- AM and early afternoon dosing avoids insomnia — skip late-day use
- Key use: Focus, mood lift, and racetam stack potentiation; prevents racetam headaches at 250–500 mg/day
- Stacks well with caffeine, L-theanine, tyrosine, or omega-3s for cognitive/mood optimization
- Advanced protocols: Up to 2,000 mg/day for TBI, stroke, or heavy neuroprotection — higher doses are clinically validated but rarely needed for healthy users
- Safety profile is excellent — GI upset or headaches at >1,000 mg/day are the only consistent issues, both easily managed by dose adjustment
- No PCT needed, no hormonal axis or withdrawal concern, and OTC legal status
If you want a clean, well-tolerated cognitive boost or reliable racetam insurance, CDP-choline is a proven base — simple, scalable, and nearly side effect–free at the doses most people run.